Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of Immunonutritional Supplement After Total Gastrectomy in Patients With Stage III Gastric Cancer on Long-term Disease-free Survival After Total Gastrectomy in Patients With Stage III Gastric Cancer

NCT05253716 is registered in ClinicalTrials.gov with Jinling Hospital, China as lead sponsor.

NCT NCT05253716
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05253716 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of Immunonutritional Supplement After Total Gastrectomy in Patients With Stage III Gastric Cancer on Long-term Disease-free Survival After Total Gastrectomy in Patients With Stage III Gastric Cancer
Lead sponsor
Jinling Hospital, China
Phase
Not applicable
Overall status
Unknown status
Start date
August 1, 2022
Completion date
March 31, 2026
Enrollment
696 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stage iii gastric cancer